Utikal J - Search Results

1

D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress.

Desch A, Gebhardt C, Utikal J, Schneider SW. Desch A, et al. Among authors: utikal j. Int J Cancer. 2017 Feb 15;140(4):914-921. doi: 10.1002/ijc.30498. Epub 2016 Nov 14. Int J Cancer. 2017. PMID: 27813063

2

c-MYC and nodular malignant melanoma. A case report.

Greulich KM, Utikal J, Peter RU, Krähn G. Greulich KM, et al. Among authors: utikal j. Cancer. 2000 Jul 1;89(1):97-103. doi: 10.1002/1097-0142(20000701)89:1<97::aid-cncr14>3.0.co;2-0. Cancer. 2000. PMID: 10897006

3

Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.

Utikal J, Udart M, Leiter U, Peter RU, Krähn G. Utikal J, et al. Int J Oncol. 2005 Mar;26(3):597-605. Int J Oncol. 2005. PMID: 15703813

4

Acute disseminated erythematous papulovesicular skin lesions in a 7-year-old child: a quiz. Diagnosis: vesicular Gianotti-Crosti syndrome.

Linke M, Géraud C, Schneider SW, Goerdt S, Utikal J. Linke M, et al. Among authors: utikal j. Acta Derm Venereol. 2011 Jun;91(4):491-4. doi: 10.2340/00015555-1018. Acta Derm Venereol. 2011. PMID: 21103846 Free article. No abstract available.

5

Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells.

Peitsch WK, Doerflinger Y, Fischer-Colbrie R, Huck V, Bauer AT, Utikal J, Goerdt S, Schneider SW. Peitsch WK, et al. Among authors: utikal j. PLoS One. 2014 Feb 18;9(2):e89491. doi: 10.1371/journal.pone.0089491. eCollection 2014. PLoS One. 2014. PMID: 24558503 Free PMC article.

6

Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib.

Gebhardt C, Staub J, Schmieder A, Goerdt S, Utikal J. Gebhardt C, et al. Among authors: utikal j. Acta Derm Venereol. 2015 Jan;95(1):96-7. doi: 10.2340/00015555-1869. Acta Derm Venereol. 2015. PMID: 24710689 Free article. No abstract available.

7

Extracellular adenosine metabolism in immune cells in melanoma.

Umansky V, Shevchenko I, Bazhin AV, Utikal J. Umansky V, et al. Among authors: utikal j. Cancer Immunol Immunother. 2014 Oct;63(10):1073-80. doi: 10.1007/s00262-014-1553-8. Epub 2014 Apr 23. Cancer Immunol Immunother. 2014. PMID: 24756420 Free PMC article. Review.

8

Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letter.

Bernhardt M, Orouji E, Larribere L, Gebhardt C, Utikal J. Bernhardt M, et al. Among authors: utikal j. Clin Cancer Res. 2014 May 1;20(9):2498-9. doi: 10.1158/1078-0432.CCR-13-2349. Clin Cancer Res. 2014. PMID: 24789037 No abstract available.

9

Complete remission of treatment-refractory advanced angiosarcoma of the scalp by protracted intralesional interleukin-2 therapy.

Gebhardt C, Ziegler B, Stadler S, Goerdt S, Utikal J. Gebhardt C, et al. Among authors: utikal j. Br J Dermatol. 2015 Apr;172(4):1156-8. doi: 10.1111/bjd.13400. Epub 2015 Feb 25. Br J Dermatol. 2015. PMID: 25204400 No abstract available.

10

Myeloid-derived suppressor cells in malignant melanoma.

Umansky V, Sevko A, Gebhardt C, Utikal J. Umansky V, et al. Among authors: utikal j. J Dtsch Dermatol Ges. 2014 Nov;12(11):1021-7. doi: 10.1111/ddg.12411. Epub 2014 Sep 28. J Dtsch Dermatol Ges. 2014. PMID: 25263083 Review. English, German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters